US Stock MarketDetailed Quotes
ARWR Arrowhead Pharmaceuticals
- 22.730
- -1.190-4.97%
Close Dec 11 16:00 ET
- 22.990
- +0.260+1.14%
Post 20:01 ET
2.83BMarket Cap-4.55P/E (TTM)
24.250High22.610Low1.57MVolume23.920Open23.920Pre Close36.13MTurnover1.42%Turnover RatioLossP/E (Static)124.43MShares39.83052wk High15.26P/B2.51BFloat Cap17.05052wk Low--Dividend TTM110.65MShs Float162.500Historical High--Div YieldTTM6.86%Amplitude1.200Historical Low23.042Avg Price1Lot Size
Arrowhead Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (FY)Sep 30, 2024 | (Q4)Sep 30, 2024 | (Q3)Jun 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q3)Jun 30, 2023 | (Q2)Mar 31, 2023 | (Q1)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -98.52%3.55M | 0 | 0 | 0 | -94.32%3.55M | -1.03%240.74M | -49.02%16.1M | -51.18%15.83M | -3.65%146.27M | 127.95%62.55M |
| Operating revenue | -98.52%3.55M | --0 | --0 | --0 | -94.32%3.55M | -1.03%240.74M | -49.02%16.1M | -51.18%15.83M | -3.65%146.27M | 127.95%62.55M |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 35.65%604.63M | 30.36%162.2M | 48.61%176.14M | 28.63%126.19M | 33.83%140.1M | 5.69%445.74M | 7.82%124.43M | 12.54%118.53M | -11.02%98.1M | 15.34%104.68M |
| Selling and administrative expenses | 6.48%96.82M | 6.70%25.79M | -0.73%23.2M | 8.01%24.64M | 12.69%23.19M | -26.92%90.93M | -27.29%24.17M | -28.62%23.37M | -32.62%22.82M | -16.31%20.58M |
| -General and administrative expense | 6.48%96.82M | 6.70%25.79M | -0.73%23.2M | 8.01%24.64M | 12.69%23.19M | -26.92%90.93M | -27.29%24.17M | -28.62%23.37M | -32.62%22.82M | -16.31%20.58M |
| Research and development costs | 43.23%505.87M | 36.02%135.83M | 60.87%152.43M | 35.04%101.12M | 39.19%116.49M | 18.80%353.19M | 19.76%99.86M | 31.28%94.76M | -1.45%74.88M | 27.26%83.7M |
| Depreciation amortization depletion | 20.04%1.94M | 45.93%591K | 26.98%513K | 4.94%425K | 2.23%412K | --1.62M | --405K | 0.25%404K | 0.25%405K | 0.00%403K |
| -Depreciation and amortization | 20.04%1.94M | 45.93%591K | 26.98%513K | 4.94%425K | 2.23%412K | --1.62M | --405K | 0.25%404K | 0.25%405K | 0.00%403K |
| Operating profit | -193.21%-601.08M | -49.73%-162.2M | -71.51%-176.14M | -362.00%-126.19M | -224.07%-136.55M | -14.84%-205M | -29.23%-108.33M | -40.86%-102.7M | 15.91%48.17M | 33.46%-42.13M |
| Net non-operating interest income expense | -218.20%-9.63M | -442.99%-7.48M | 242.39%1.4M | -100.00%-994K | -1,435.93%-2.57M | -160.14%-3.03M | -186.99%-1.38M | -179.52%-986K | -147.15%-497K | -114.45%-167K |
| Non-operating interest income | 48.51%22.72M | 84.56%7.17M | 55.75%6.5M | 37.06%6.25M | 4.47%2.8M | 203.97%15.3M | 145.42%3.89M | 236.45%4.17M | 332.64%4.56M | --2.68M |
| Non-operating interest expense | 76.54%32.35M | 178.35%14.65M | -1.24%5.09M | 43.25%7.24M | 88.38%5.37M | --18.33M | --5.26M | --5.16M | --5.06M | --2.85M |
| Other net income (expense) | -213.65%-1.75M | -534.87%-3.12M | 148.37%760K | 2,262.50%189K | -16.96%421K | 101.05%1.54M | 696.67%717K | 181.17%306K | -99.55%8K | 171.71%507K |
| Other non- operating income (expenses) | -213.65%-1.75M | -534.87%-3.12M | 148.37%760K | 2,262.50%189K | -16.96%421K | 101.05%1.54M | 696.67%717K | 181.17%306K | -99.55%8K | 171.71%507K |
| Income before tax | -196.60%-612.46M | -58.54%-172.8M | -68.28%-173.98M | -366.37%-127M | -231.84%-138.69M | -19.56%-206.49M | -32.66%-108.99M | -43.50%-103.38M | 7.46%47.68M | 33.53%-41.79M |
| Income tax | -199.39%-2.77M | -73.04%546K | 0 | 0 | -19,588.24%-3.31M | -26.45%2.78M | -46.50%2.03M | 742K | 0 | 17K |
| Net income | -191.34%-609.69M | -56.14%-173.34M | -67.08%-173.98M | -366.37%-127M | -223.78%-135.38M | -18.57%-209.28M | -29.17%-111.02M | -44.53%-104.13M | 7.46%47.68M | 33.50%-41.81M |
| Net income continuous Operations | -191.34%-609.69M | -56.14%-173.34M | -67.08%-173.98M | -366.37%-127M | -223.78%-135.38M | -18.57%-209.28M | -29.17%-111.02M | -44.53%-104.13M | 7.46%47.68M | 33.50%-41.81M |
| Minority interest income | -155.00%-10.2M | -110.18%-2.81M | -170.06%-3.18M | -69.77%-1.7M | -416.87%-2.51M | -828.07%-4M | -209.98%-1.34M | -1.18M | -999K | -486K |
| Net income attributable to the parent company | -192.04%-599.49M | -55.49%-170.54M | -65.91%-170.79M | -357.42%-125.3M | -221.51%-132.86M | -16.59%-205.28M | -28.26%-109.68M | -42.89%-102.95M | 9.71%48.68M | 34.27%-41.33M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -192.04%-599.49M | -55.49%-170.54M | -65.91%-170.79M | -357.42%-125.3M | -221.51%-132.86M | -16.59%-205.28M | -28.26%-109.68M | -42.89%-102.95M | 9.71%48.68M | 34.27%-41.33M |
| Basic earnings per share | -160.42%-5 | -34.31%-1.37 | -43.75%-1.38 | -321.74%-1.02 | -217.95%-1.24 | -14.97%-1.92 | -25.93%-1.02 | -41.18%-0.96 | 9.52%0.46 | 35.00%-0.39 |
| Diluted earnings per share | -160.42%-5 | -34.31%-1.37 | -43.75%-1.38 | -326.67%-1.02 | -217.95%-1.24 | -14.97%-1.92 | -25.93%-1.02 | -41.18%-0.96 | 9.76%0.45 | 35.00%-0.39 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Heat List
US
Overall
Symbol
Price
% Chg
No Data